Part B of MoveDMD Trial Shows Mixed Efficacy Results for CAT-1004 as Duchenne Treatment

Part B of MoveDMD Trial Shows Mixed Efficacy Results for CAT-1004 as Duchenne Treatment

Catabasis Pharmaceuticals reported mixed topline data from Part B of the MoveDMD trial evaluating the safety and efficacy of CAT-1004 (edasalonexent) in treating Duchenne muscular dystrophy (DMD) patients. MoveDMD is a three-part, multisite Phase 1/2 trial (NCT02439216) evaluating the efficacy, safety, and the pharmacodynamics (PD) and pharmacokinetics (PK),…

6 Educational Resources From the Muscular Dystrophy Association

When your child starts school you may need some help settling in and preparing the school and teachers for meeting your child’s needs. The Muscular Dystrophy Association (MDA) offers a range of educational resources designed to help children with muscular dystrophy and spinal muscular atrophy (SMA) get the most…

Early Signs of Duchenne Muscular Dystrophy

https://www.youtube.com/watch?v=KW4WvLd5NqY This video from the World Duchenne Awareness Day shares some of the early symptoms of Duchenne muscular dystrophy. It’s estimated that one in 3500 boys will be born with Duchenne muscular dystrophy but most won’t present any symptoms of the disease until they are two or three years old.

3-Year-Old MD Patient Completes Half-Marathon With Dad

Most three-year-olds only get to watch marathons from the sidelines or on television, but not Levi Gagner. The Rare Disease Report revealed that Levi, along with his dad Kyle, completed the Rock ‘n’ Roll half marathon last weekend. The Pheonix, Arizona event is the third race the two have competed…